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Abstract
Optimal nutritional support is considered to be an integral part in the management of cystic fibrosis (CF). Several factors
contribute to increased resting energy expenditure (REE), which itself can lead to energy imbalance and thus contribute to
deterioration of the nutritional status. We aimed to assess the impact of lung parenchyma damage on REE and correlated these
findings with forced expiratory volume in 1 s (FEV ). Twenty patients performed respiratory function testing (FEV ), pulmonary1 1
high-resolution computed tomography (HRCT) and assessment of REE with open circuit indirect calorimetry. HRCT was scored
by using a modified Bhalla method. Mean HRCT score was 8.4 and mean REE value was 108.4% predicted vs. 96.5% predicted
of 16 healthy subjects (P-0.01). There was a significant correlation between HRCT score and REE (P-0.01), HRCT score and
FEV (P-0.001) and REE and FEV (P-0.05). The correlations demonstrate a close correlation between lung damage and1 1
elevated REE in people with CF. Prevention of negative energy balance is an important part in follow-up of patients with CF.
Any increase in REE should raise suspicion of progress in lung impairment.
 2002 European Cystic Fibrosis Society. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Optimal nutrition is a major cornerstone in the man-
agement of cystic fibrosis (CF). Long term follow-up
of CF patients has shown significantly better survival in
patients who achieved normal nutritional status w1x. The
gold standard for determining individual energy needs
in patients with CF is resting energy expenditure (REE)
measured by indirect calorimetry. REE in CF patients is
increased due to repetitive lung infections and lung
inflammation w1x, increased respiratory effort and pos-
sibly as a direct result of the underlying genetic abnor-
mality w2x. Total energy expenditure though can remain
normal due to reduced physical activity w1x.
Pulmonary high-resolution computed tomography
(HRCT) has been considered as the most promising
imaging technique to assess pulmonary architectural
abnormalities in patients with CF w3–5x.
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To answer the question whether there is a correlation
between lung disease and resting energy expenditure,
we examined our patients with indirect calorimetry, and
correlated these findings with HRCT score and forced
expiratory volume in 1 s (FEV , % predicted).1
2. Materials and methods
Haukeland University Hospital serves as a regional
centre for CF patients in Western Norway. The study
included 20 patients (10 females) from our cohort of
patients with CF with a mean age of 14 years, S.D. 7
years, range 6–34 years and a median of 12.5 years.
The CF diagnosis was made by demonstration of repeat-
ed elevated sweat chloride concentrations and typical
clinical manifestations in all patients. Eight patients
were found to be homozygous for the dF508 mutation
(40%); the remaining 12 patients did either have two
other mutations (3 patients), one detectable mutation (4
patients) or no mutation has been found so far (5
patients). All patients had received conventional therapy
for CF for at least 6 months and they were in clinically
stable condition.
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Table 1
General patient data, mean values"S.D. Ranges in parentheses
Ns20
Chloride sweat in mmolyl 101"22
(62–138)




FVC—forced vital capacity in 92.3"20.9
percent of predicted (47–126)
FEV —forced expiratory volume1 78.2"22.6
in 1 s in percent of predicted (25–112)
Data were collected between February 1999 and
August 2000. Informed consent was obtained from
patients andyor their families. The regional ethics com-
mittee approved our study protocol.
General patient data, characterizing our study popu-
lation, are shown in Table 1.
Our patients attend the outpatient department every
2 –3 month, or more often when needed. Sevennd rd
patients (35%) have chronic lung infection with Pseu-
domonas aeruginosa and they have been given 12-day
courses of intravenous antibiotic treatment every 3rd
month.
We performed standard computerised open-circuit
indirect calorimetry (Sensor Medics Vmax, USA) after
12 h fasting, with at least 4 h restriction of using b-2
inhalative agents. The patients were placed under the
canopy hood in a relaxed, supine position. Respiratory
gas exchange was monitored for 10 min to allow
acclimatisation, a subsequent 20-min measurement peri-
od was used to calculate REE based on the abbreviated
Weir formula w6x.
Pulmonary HRCT was performed the same day (Gen-
eral Electrics, HiSpeed CT) using 1-mm-thin sections
and 10-mm intervals during inspiration, followed by 1-
mm-thin sections with 20-mm intervals during expira-
tion. A paediatric radiologist evaluated the HRCT
images, and classified the findings according to a mod-
ified scoring system based on Bhallas and colleagues
w7x. The morphological criteria were based on descrip-
tion of localisation and degree of pathological changes.
According to Bhalla we evaluated bronchiectasis, peri-
bronchial thickening, mucus plugging, sacculations, bul-
lae, emphysema and collapse or consolidation. The
scoring system was extended in terms of mosaic perfu-
sion according to Helbich and colleagues w4x. The
maximal obtainable score was 27.
Clinical status was evaluated by using a Shwachman–
Kulczycki score w8x. Standard spirometry was assessed
by Sensor Medics Vmax (USA) equipment.
We also examined 16 healthy subjects (7 female,
median age 12 years, range 8–33 years) with indirect
calorimetry in order to verify our predicted values of
REE.
Data analysis was performed using a commercially
available software package (SPSS). Descriptive statistics
included mean, minimum and maximum values, S.D.
and median. Differences in REE (% predicted) between
healthy subjects and CF patients were tested using a
Student’s t-test and a Wilcoxon–Mann–Whitney test.
The relation between HRCT score and REE (% predict-
ed), HRCT score and FEV (% predicted) and REE (%1
predicted) and FEV (% predicted) were assessed by1
the Pearson correlation coefficient. All reported P values
are two-tailed and P-0.05 was considered significant.
3. Results
The mean HRCT score in our CF group was 8.4"6.1
(S.D.) ranging from 1 to 22 (median 7.5). Bronchiec-
tasis was the most frequent finding (17 of 20 patients,
85%). Bronchiectasis were graded as mild in ten, mod-
erate in five and serious in two of these 17 patients.
Peribronchial thickening was the second most common
finding and was found in 15 patients (75%); all of them
were graded as mild. Mucus plugging was present in 14
patients (70%), eight patients had mucus plugging in
1–5 bronchopulmonary segments, one patient had
mucus plugging in 6–9 segments and five patients in
more than nine segments. Moreover, we detected con-
solidations in 12 patients, sacculations in 6 patients,
mosaic perfusion in 6 patients and bullae in 2 patients.
No patient had abscesses or emphysema. None scored
zero.
The mean value of resting energy expenditure was
108.4"15.4% predicted in our CF population. In healthy
subjects a mean value of 96.5"8.7% predicted was
found, which was significantly lower (P-0.01). CF
patients, homozygous for the dF508 mutation had a
mean REE of 112.3% predicted (S.D. 10.8), the remain-
ing patients had a mean REE of 105.8 (S.D. 17.9). This
difference, however, was not statistically significant.
Individual results of HRCT score, REE (% predicted),
FEV (% predicted) and chronic Pseudomonas aerugi-1
nosa infection are presented in Table 2.
There was a significant correlation between HRCT
score and REE (% predicted, rs0.661, P-0.01). Fig.
1 shows the correlation between REE (% predicted) and
HRCT score. High resting energy expenditure was cor-
related with high HRCT score.
Furthermore, there was a significant negative corre-
lation between HRCT score and FEV (% predicted,1
rsy0.851, P-0.001; Fig. 2).
There was as well a weak, yet significant correlation
between REE (% predicted) and FEV (% predicted)1
with P-0.05 (rsy0.454) (Fig. 3).
4. Discussion
We have found significant correlation between pul-
monary HRCT findings, scored with a modified Bhalla
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Table 2
Individual results in 20 patients with cystic fibrosis and mean (S.D.)
values
Patient Age HRCT REE FEV1 PSAa
(years) Score (% pred.) (% pred.)
1 6 5 109 99 y
2 8 10 103 73 q
3 8 1 81 85 y
4 8 7 119 78 y
5 9 8 110 82 y
6 10 3 117 95 y
7 12 9 99 74 y
8 12 15 103 65 q
9 12 7 121 71 y
10 12 15 120 55 q
11 13 1 89 98 y
12 13 5 87 101 y
13 13 1 100 112 y
14 17 8 120 109 y
15 17 9 119 69 q
16 17 22 132 25 q
17 21 3 105 91 y
18 22 4 88 84 y
19 23 15 106 37 q
20 34 19 140 61 q
Mean 14"7 8.4"6.1 108.4"15.4 78.2"22.6 7
(S.D.) (35%)
PSAschronic Pseudomonas aeruginosa lung infection.a
Fig. 1. Correlation between resting energy expenditure percentage predicted (REE, %predicted) and HRCT score (rs0.661, P-0.01); the graph
reflects a regression line.
score, REE and lung function as measured by FEV in1
CF patients. Moreover, REE correlated significantly with
FEV . Thus there seems to be an impact of lung1
pathology on resting energy expenditure.
Pulmonary HRCT permits evaluation of the lung
parenchyma abnormalities in detail w4,9x. Even minor
morphologic changes in serial CT scans before and after
treatment of acute pulmonary exacerbation can be eval-
uated w10x. HRCT scans confer complete information of
the distribution and severity of lung damage w11x and
scoring of the pathological findings carry the opportunity
to quantify structural lung damage.
According to previous investigations, chronic pulmo-
nary inflammation, which leads to deterioration of the
lung function, is the major factor associated with
increased REE in patients with CF w1,12x. Once FEV1
falls below 75% of predicted values, the REE raises in
a curvilinear (quadratic) fashion w13x. Little, if any
increase in REE is seen in well-nourished CF males
with well-preserved lung function w13x, although Bowler
and colleagues showed increased REE in CF patients
with mild lung involvement w14x. The degree of paren-
chymal lung damage seems to play a major role in the
interaction between increased REE and lung function as
measured as FEV .1
REE decreases significantly during intravenous anti-
biotic treatment in patients chronically infected with
Pseudomonas aeruginosa w15,16x. This may indicate
that lung infection is the denominator in the interrela-
tionship between lung damage and REE. The increased
energy expenditure returns to pre-treatment levels some
weeks after the infection has been treated w1x. We have
observed similar trends (unpublished data). According
to Stallings w17x, treatment of acute pulmonary exacer-
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Fig. 2. Correlation between forced expiratory volume in 1 s (FEV , % predicted) and HRCT score (rsy0.851, P-0.001); the graph reflects a1
regression line.
Fig. 3. Correlation between resting energy expenditure percentage predicted (REE, %predicted) and forced expiratory volume in 1 s (FEV , %1
predicted), rsy0.454, P-0.05; the graph reflects a regression line.
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bation in children with mild to moderate lung disease is
not associated with increase above baseline REE. How-
ever, lung function as measured by FEV is improving1
significantly after treatment w17x.
Increased REE has been reported in CF patients,
homozygous for the dF508 mutation w8,18x, and in
patients who are colonised with Pseudomonas species.
w19x. We found a higher mean REE in our homozygous
dF508 patients though not statistically significant. This
may be due to limited number of patients. Pencharz w1x
and Wilson w20x have concluded from their investiga-
tions that the genetic defect itself appears to have a
minor, if any effect on REE.
We found a significant negative correlation between
HRCT score and FEV (% predicted) in our patients.1
This is in accordance with previously reported findings
w3,21x.
To our knowledge, the correlation between resting
energy expenditure and HRCT scan findings in patients
with CF has not been reported before. It indicates a
close relation between lung damage and caloric require-
ment reflecting the complex interaction between lung
inflammation, bacterial infection, malnutrition and pos-
sibly the nature of the mutation in a vicious circle in
CF patients. During the last 15 years, it has become
increasingly clear that nutritional status has an impact
on lung disease and lung function in CF patients w22x.
This connection is demonstrated also in our study. We
have shown a significant correlation between lung func-
tion as measured by FEV , and both HRCT score and1
REE. Several factors play their part in these complicated
interactions, and we think that the inflammatory proc-
esses in the lungs are important. Investigating markers
of inflammation and correlating them with REE would
be of particular interest, and we intend to look at these
aspects in the near future.
In addition to increased energy losses due to the
exocrine pancreatic insufficiency, higher energy con-
sumption could be explained by the interactions
described in this paper, and these factors altogether
make a basis for the concept that patients with CF need
to have a high-energy intake.
Our findings may contribute to additional information
regarding the destructive process in the CF lung, which
was excellently demonstrated by Schoni and colleagues¨
w23x. They defined lung damage from underlying disease
and weight loss as crucial components in the pathogen-
esis of lung destruction. Focus of intervention should
therefore concentrate on both components as early as
possible.
Prevention of a negative energy balance is an impor-
tant part of the surveillance of the patients with CF. One
should therefore be aware of progress in lung impairment
when increased REE is found.
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